Related Experiment Video
Updated: Feb 22, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Response to "Letter to Editor reply: Interpreting fibrosis markers in psychoactive substance use disorders: Key
Iva Kosuta1,2,3, Lea Kozina4, Paula Cizmic5
1Division of Intensive Care, Department of Internal Medicine, University Hospital Centre Zagreb, Ulica Mije Kispatica 12, 10000, Zagreb, Croatia. ikosuta@kbc-zagreb.hr.
No abstract available in PubMed .
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Abuse and Addiction: Pharmacological Phenomena
Therapeutic Drug Monitoring: Affecting Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

